Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Protagenic Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$4.48 | -$4.48 | -$4.48 |
| Q2 2025 | 1 | -$2.80 | -$2.80 | -$2.80 |
Protagenic Therapeutics, Inc. Earnings Date And Information
Protagenic Therapeutics, Inc. last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Protagenic Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.13 diluted earnings per share) and currently has a price-to-earnings ratio of -0.33. Protagenic Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 19th, 2025 based on prior year's report dates.
Protagenic Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/13/2025 | Q1 2025 | N/A | -$2.75 | N/A | N/A | $0 |
| 03/31/2025 | Q4 2024 | N/A | -$0.33 | N/A | N/A | $0 |
| 11/14/2024 | Q3 2024 | N/A | -$0.14 | N/A | N/A | $0 |
| 08/14/2024 | Q2 2024 | N/A | -$0.36 | N/A | N/A | $0 |
| 05/15/2024 | Q1 2024 | N/A | -$0.39 | N/A | N/A | $0 |
| 04/01/2024 | Q4 2023 | N/A | -$0.38 | N/A | N/A | $0 |
| 11/14/2023 | Q3 2023 | N/A | -$0.32 | N/A | N/A | $0 |
| 08/14/2023 | Q2 2023 | N/A | -$0.28 | N/A | N/A | $0 |
| 05/15/2023 | Q1 2023 | N/A | -$0.17 | N/A | N/A | $0 |
| 03/31/2023 | Q4 2022 | N/A | -$0.14 | N/A | N/A | $0 |
| 11/14/2022 | Q3 2022 | N/A | -$0.21 | N/A | N/A | $0 |
| 08/11/2022 | Q2 2022 | N/A | -$0.15 | N/A | N/A | $0 |
| 05/13/2022 | Q1 2022 | N/A | -$0.32 | N/A | N/A | $0 |
| 04/07/2022 | Q4 2021 | N/A | -$0.22 | N/A | N/A | $0 |
| 11/15/2021 | Q3 2021 | N/A | -$0.20 | N/A | N/A | $0 |
| 08/16/2021 | Q2 2021 | N/A | -$0.44 | N/A | N/A | $0 |
| 05/17/2021 | Q1 2021 | N/A | -$0.44 | N/A | N/A | $0 |
| 03/25/2021 | Q4 2020 | N/A | -$0.20 | N/A | N/A | $0 |
| 11/16/2020 | Q3 2020 | N/A | -$0.41 | N/A | N/A | $0 |
| 08/14/2020 | Q2 2020 | N/A | -$0.22 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Protagenic Therapeutics, Inc. Earnings: FAQ's
Protagenic Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 19th, 2025 based offlast year's report dates.
The conference call for Protagenic Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Protagenic Therapeutics, Inc.'s latest earnings report can be read online.
Protagenic Therapeutics, Inc. (:PTIXW) has a recorded net income of $-5,525,000.Protagenic Therapeutics, Inc. has generated $-1.13 earnings per share over the last four quarters.
Protagenic Therapeutics, Inc. (:PTIXW) has a price-to-earnings ratio of -0.33 and price/earnings-to-growth ratio is 0.